Fluzone Trivalent Northern Hemisphere Injection, Suspension
Product Images NDC 49281-426

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fluzone Trivalent Northern Hemisphere (NDC 49281-426). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi Vaccines Us Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (5 mL Vial Package)

Packaging label for FLUZONE Influenza Vaccine 2026-2027 Formula, 5 mL multi-dose vial by Sanofi Vaccines US Inc. Indicated for intramuscular use in individuals 6 months and older with dosing instructions for 6-35 months and 3 years and older. Includes storage instructions and strain composition details for the 2026-2027 influenza season.*

FDA Label Image

Principal Display Panel (0.5 mL Syringe Package)

Packaging label for FLUZONE Trivalent Northern Hemisphere Influenza Vaccine, 2026-2027 Formula, by Sanofi Vaccines US Inc. The label indicates 10 single-dose prefilled syringes, 0.5 mL each, for intramuscular use in individuals 6 months of age and older. The box includes storage instructions and basic vaccine information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.